EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Donor lymphocyte infusions: An experience from a tertiary care center of North India

Divjot Singh Lamba, Parmatma Prasad Tripathi, Rekha Hans, Alka Khadwal, Ratti Ram Sharma

Asian Journal of Transfusion Science · 2024-01 · 18 (1) · 124-127

DOI: 10.4103/ajts.ajts_211_23 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Asian Journal of Transfusion Science, online erschienen am 21.06.2024. Verfasst von Divjot Singh Lamba und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transfusion Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Donor lymphocyte infusions (DLIs) are often recommended products after allogeneic hematopoietic stem cell transplant to increase graft – versus – leukemia effect. More success rate of DLI has been reported in relapsed posttransplant chronic myeloid leukemia. Whatever the indication for DLI, mortality related to post-DLI infusion is 5%–20%, and more than one-third of patients will develop acute and/or chronic graft versus host disease (GVHD) after DLI. We report two cases where DLIs were used for residual disease after posttransplant. Both of DLI went uneventful. None of the patient’s developed signs of GVHD postinfusion. Although both patients expired with different causes, none were related to DLI infusion. Information from published literature suggests that DLI should be administered early after relapse or as a prophylactic strategy in patients receiving T-cell-depleted grafts, and patients with aggressive diseases may benefit from disease reduction before DLI. However, further evidence is required to evaluate its efficacy, especially in relapsed or residual hematological malignancies.

Schlagwörter

Stichwörter der Autor:innen

Bone marrow transplantationCD3 + cellscellular therapydonor lymphocyte infusionminimal residual disease

Autor:innen und Institutionen

  • Department of Transfusion Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Clinical Hematology and Medical Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Zitieren

APA

Lamba, D. S., Tripathi, P. P., Hans, R., Khadwal, A., & Sharma, R. R. (2024). Donor lymphocyte infusions: An experience from a tertiary care center of North India. Asian Journal of Transfusion Science, 18(1), 124-127. https://doi.org/10.4103/ajts.ajts_211_23

Vancouver

Lamba DS, Tripathi PP, Hans R, Khadwal A, Sharma RR. Donor lymphocyte infusions: An experience from a tertiary care center of North India. Asian Journal of Transfusion Science. 2024;18(1):124-127. doi:10.4103/ajts.ajts_211_23

BibTeX
@article{Lamba2024,
  author = {Lamba, Divjot Singh and Tripathi, Parmatma Prasad and Hans, Rekha and Khadwal, Alka and Sharma, Ratti Ram},
  title = {Donor lymphocyte infusions: An experience from a tertiary care center of North India},
  journal = {Asian Journal of Transfusion Science},
  year = {2024},
  volume = {18},
  number = {1},
  pages = {124--127},
  doi = {10.4103/ajts.ajts_211_23}
}
Kostenlos starten →